​

Funding Round

Series B - Deka Biosciences

Series B - Deka Biosciences

Investment Firm

Overview

Early stage biotechnology company

Announced Date

Sep 28, 2023

Closed on Date

Jun 01, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

8

Investor Name
Participant InvestorPlains Ventures
Participant InvestorAlexandria Venture Investments
Participant InvestorLeaps by Bayer
Participant InvestorJohn Mumm
Participant InvestorMPM Capital

Round Details and Background

Deka Biosciences raised $20000000 on 2023-09-28 in Series B

Early stage biotechnology company

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 29, 2021
Series A - Deka Biosciences
5-20.0M
Jan 01, 2022
Series B - Deka Biosciences
2-21.5M
Dec 08, 2023
Venture Round - Deka Biosciences
-29.9M
Sep 28, 2023
Series B - Deka Biosciences
10-20.0M

Recent Activity

There is no recent news or activity for this profile.